Niranjan Kanesa-thasan - Feb 2, 2022 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Chief Medical Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Stock symbol
ICVX
Transactions as of
Feb 2, 2022
Transactions value $
$52,101
Form type
4
Date filed
2/4/2022, 05:25 PM
Previous filing
Aug 2, 2021
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $11.6K +13.8K +8.19% $0.84* 182K Feb 2, 2022 Direct
transaction ICVX Common Stock Options Exercise $40.5K +38.9K +21.35% $1.04* 221K Feb 2, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -13.8K -45.83% $0.00 16.3K Feb 2, 2022 Common Stock 13.8K $0.84 Direct F1
transaction ICVX Stock Option Right to Buy) Options Exercise $0 -38.9K -25% $0.00 117K Feb 2, 2022 Common Stock 38.9K $1.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 4/1/2021, and 1/48th of the shares subject to the option vest monthly thereafter.
F2 25% of the shares subject to the option vested on 1/14/2022, and 1/48th of the shares subject to the option vest monthly thereafter.